Cravath Swaine & Moore represented Ashland Inc. in the transaction. Ashland Inc. (NYSE: ASH) announced that it has signed a definitive agreement to sell its nutraceuticals...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here